公开(公告)号：US20190038695A1

公开(公告)日：2019-02-07

申请号：US15759052

申请日：2016-09-09

申请人： Ming Jin

发明人： Ming Jin

IPC分类号： A61K36/481 ,  A61K36/36 ,  A61K36/54 ,  A61K36/232 ,  A61K36/258 ,  A61K36/894 ,  A61K36/537 ,  A61K36/64 ,  A61K36/28 ,  A61K35/62 ,  A61P27/02

CPC分类号： A61K36/481 ,  A61K35/62 ,  A61K36/232 ,  A61K36/258 ,  A61K36/28 ,  A61K36/284 ,  A61K36/36 ,  A61K36/537 ,  A61K36/54 ,  A61K36/64 ,  A61K36/804 ,  A61K36/894 ,  A61K36/8945 ,  A61P27/02 ,  A61K2300/00

摘要： The present invention provides a traditional Chinese medicine (TCM) composition for the treatment of diabetic retinopathy, wherein the active pharmaceutical ingredients (APIs) of the said TCM composition are: Astragali Radix 10-80 parts by weight, Pseudostellariae Radix 5-30 parts by weight, Cinnamomi Ramulus 3-25 parts by weight, Angelicae Sinensis Radix 8-60 parts by weight, Notoginseng Radix ET Rhizoma 2-15 parts by weight, Dioscoreae Rhizoma 10-80 parts by weight, Salviae Miltiorrhizae Radix ET Rhizoma 10-80 parts by weight, Pheretima 2-15 parts by weight, Rehmanniae Radix 8-60 parts by weight, and Atractylodis Macrocephalae Rhizoma 8-60 parts by weight. It has been shown by clinical experiments that, the invented TCM composition has an exact efficacy in patients with macular edema and can effectively improve the patients' visual acuity and visual field and relieve ocular fundus diseases, playing an active role in alleviating macular edema.

公开(公告)号：US20180344676A1

公开(公告)日：2018-12-06

申请号：US15764902

申请日：2016-09-29

申请人： George Edward Hoag

发明人： George Edward Hoag

IPC分类号： A61K31/196 ,  A61K9/06 ,  A61K9/00 ,  A61K47/46 ,  A61K47/32 ,  A61K47/26 ,  A61P25/00

CPC分类号： A61K31/06 ,  A61K9/0014 ,  A61K9/06 ,  A61K31/045 ,  A61K31/192 ,  A61K31/196 ,  A61K31/202 ,  A61K31/352 ,  A61K31/405 ,  A61K31/5415 ,  A61K31/618 ,  A61K36/185 ,  A61K36/45 ,  A61K36/53 ,  A61K36/534 ,  A61K36/537 ,  A61K36/55 ,  A61K36/61 ,  A61K45/06 ,  A61K47/26 ,  A61K47/32 ,  A61K47/46 ,  A61P29/00 ,  A61K2300/00

摘要： This disclosure relates to natural topical and analgesic pain relief and anti-inflammation compositions and methods to reduce pain and inflammation. This disclosure also relates to the use of cannabinoid compounds in hydrophilic compositions comprised of synthetic and natural plant extract compounds that are multifunctional TRPM8 ion channel agonists, TRPA1 and TRPV1 ion channel antagonists, CGRP antagonists, COX-2 inhibitors and CB1 and CB2 antagonists. In particular, this disclosure relates to a topical analgesic composition comprising at least one synthetic or natural plant extract TRPM8 agonist, at least one synthetic or natural plant extract is a TRPA1 antagonist, and fixed plant seed oil containing Omega-3 fatty acids TRPV1 antagonists and a carrier.

公开(公告)号：US20180221425A1

公开(公告)日：2018-08-09

申请号：US15750675

申请日：2016-08-09

申请人： RED SWAN LTD.

发明人： ORLY BEN-LULU ,  EFRAT ALGRESSI

IPC分类号： A61K36/28 ,  A61P43/00 ,  A61K9/00 ,  A61K47/44 ,  A61K47/10 ,  A61K36/61 ,  A61K35/644 ,  A61K9/06 ,  A61K36/30 ,  A61K36/185 ,  A61K36/53 ,  A61K36/752 ,  A61K36/537 ,  A61K36/54 ,  A61K31/07 ,  A61K31/355 ,  A61K36/71 ,  A61K36/23 ,  A61K36/738 ,  A61K36/899 ,  A61K36/67 ,  A61K36/85 ,  A61K45/06

CPC分类号： A61K36/28 ,  A61K9/0014 ,  A61K9/06 ,  A61K31/07 ,  A61K31/355 ,  A61K35/644 ,  A61K36/185 ,  A61K36/23 ,  A61K36/30 ,  A61K36/53 ,  A61K36/537 ,  A61K36/54 ,  A61K36/61 ,  A61K36/67 ,  A61K36/71 ,  A61K36/738 ,  A61K36/752 ,  A61K36/85 ,  A61K36/899 ,  A61K45/06 ,  A61K47/10 ,  A61K47/44 ,  A61P17/02 ,  A61P43/00 ,  A61K2300/00

摘要： Methods and compositions for treating wounds are described. The compositions include core active ingredients derived from the genera of: Calendula, Achillea Millefolium, Syzygium Aromaticum and Helichrysum. The methods include mixing the core active ingredients, preferably with other secondary active ingredients, adjuvants or excipients, to form the composition and administering the composition by topically applying an effective amount of the composition onto a wound or incision of a patient.

公开(公告)号：US09999644B2

公开(公告)日：2018-06-19

申请号：US15023390

申请日：2014-09-16

申请人： CARE 4 STYLE LTD

发明人： Yeheskel Tsion

IPC分类号： A61K36/00 ,  A61K36/537 ,  A61K36/84 ,  A61K31/593 ,  A61K33/06 ,  A61K36/16 ,  A61K31/202 ,  A61K31/355 ,  A61K31/4415 ,  A61K9/00 ,  A61K9/20 ,  A61K9/48 ,  A61K31/194 ,  A61K33/10 ,  A61K33/26 ,  A61K36/35 ,  A61K9/08

CPC分类号： A61K36/537 ,  A61K9/0053 ,  A61K9/08 ,  A61K9/20 ,  A61K9/48 ,  A61K9/4841 ,  A61K31/194 ,  A61K31/202 ,  A61K31/355 ,  A61K31/4415 ,  A61K31/593 ,  A61K33/06 ,  A61K33/10 ,  A61K33/26 ,  A61K36/16 ,  A61K36/35 ,  A61K36/84 ,  A61K2300/00

摘要： Provided herein are compositions, methods of use thereof and kits comprising same for prophylaxis, alleviating or treating a subject with, or experiencing symptoms associated with, attention deficit disorder/attention deficit hyperactivity disorder (ADD/ADHD) and related disorders. Specifically, the compositions comprise a magnesium mineral, vitamin D and at least one botanical component, in amounts such that the supplement is effective for preventing, alleviating and/or treating a child, teen or adult subject with ADD/ADHD and related disorders or one or more symptoms associated with ADD/ADHD and related disorders.

公开(公告)号：US09999630B2

公开(公告)日：2018-06-19

申请号：US14903995

申请日：2014-07-11

申请人： TASLY PHARMACEUTICAL GROUP CO., LTD

发明人： Xijun Yan ,  Naifeng Wu ,  Kaijing Yan ,  Zhengliang Ye ,  Shunnan Zhang ,  Lihong Zhou ,  Wensheng Zhang ,  Hai'ou Dong

IPC分类号： A61K36/00 ,  A61K31/704 ,  A61K36/537 ,  A61K36/258 ,  A61K31/045 ,  A61K9/20 ,  A61K31/192 ,  A61K31/216 ,  A61K31/343 ,  A61K9/28

CPC分类号： A61K31/704 ,  A61K9/16 ,  A61K9/1664 ,  A61K9/20 ,  A61K9/2009 ,  A61K9/2013 ,  A61K9/2018 ,  A61K9/2031 ,  A61K9/2059 ,  A61K9/2068 ,  A61K9/2893 ,  A61K31/045 ,  A61K31/11 ,  A61K31/192 ,  A61K31/216 ,  A61K31/343 ,  A61K36/258 ,  A61K36/537 ,  A61K36/82 ,  A61K2300/00

摘要： A traditional Chinese medicine composition for treating cardiovascular disease, and a preparation thereof, particularly a micro drop pill preparation thereof, and a method for preparing the preparation; the method for preparing the micro drop pill preparation can be used to prepare drop pills, coated drop pills, and drop pill capsules with a high drug loading capacity.

公开(公告)号：US20180161385A1

公开(公告)日：2018-06-14

申请号：US15894739

申请日：2018-02-12

申请人： FAIRHAVEN HEALTH, LLC

发明人： Joanna E. ELLINGTON ,  G. Dennis CLIFTON

IPC分类号： A61K36/537 ,  A61K8/04 ,  A61K47/06 ,  A61K8/60 ,  A61Q19/10 ,  A61K9/00 ,  A61K47/10 ,  A61K47/12 ,  A61K47/38 ,  A61K47/32 ,  A61K47/22 ,  A61K47/02 ,  A61K9/06 ,  A61K31/7004 ,  A61K47/26 ,  A61K8/97

CPC分类号： A61K36/537 ,  A61K8/042 ,  A61K8/60 ,  A61K8/97 ,  A61K9/0014 ,  A61K9/0034 ,  A61K9/06 ,  A61K31/7004 ,  A61K47/02 ,  A61K47/06 ,  A61K47/10 ,  A61K47/12 ,  A61K47/22 ,  A61K47/26 ,  A61K47/32 ,  A61K47/38 ,  A61Q19/10 ,  A61K2300/00

摘要： The present disclosure provides compositions and methods for making and using topical compositions comprised of an isotonic, biome-friendly solution containing xylose and/or a Salvia extract. The compositions are useful for, for example, maintaining or enhancing female lower reproductive tract (LRT) homeostasis and physiological function. In particular, topical compositions of this disclosure can be formulated for use as a freshening, menopausal, fertility, and/or perineal composition.

公开(公告)号：US20180092958A1

公开(公告)日：2018-04-05

申请号：US15548791

申请日：2015-08-25

申请人： WONKWANG UNIVERSITY CENTER FOR INDUSTRY-ACADEMY COOPERATION

发明人： Sung Chul KIM

IPC分类号： A61K36/9066 ,  A61K36/537 ,  A61K36/8988 ,  A61K36/69 ,  A61K36/732 ,  A61K36/65 ,  A61K36/484 ,  A61K36/284

CPC分类号： A61K36/9066 ,  A61K36/284 ,  A61K36/484 ,  A61K36/537 ,  A61K36/65 ,  A61K36/69 ,  A61K36/732 ,  A61K36/8988 ,  A61K2236/33 ,  A61K2236/51 ,  A61P25/28

摘要： Disclosed herein is a pharmaceutical composition for preventing, alleviating or treating neurodegenerative diseases. The pharmaceutical composition contains, as active ingredients, Curcumae longae rhizome, Gastrodiae rhizoma, Polygalae radix, Salviae radix, Chaenomeles fructus, Paeoniae radix, Glycyrrhizae radix, Atractylodis rhizome, and Pulvis aconiti tuberis purificatum. The pharmaceutical composition is prepared by a method including the steps of: mixing Curcumae longae rhizome, Gastrodiae rhizoma, Polygalae radix, Salviae radix, Chaenomeles fructus, Paeoniae radix, Glycyrrhizae radix, Atractylodis rhizome, and Pulvis aconiti tuberis purificatum to obtain a mixture, and extracting the mixture to obtain a mixture extract; filtering the mixture extract; concentrating the mixture extract; and drying the mixture extract.

公开(公告)号：US20180054947P1

公开(公告)日：2018-02-22

申请号：US15731747

申请日：2017-07-27

申请人： Marc Vanlancker

发明人： Marc Vanlancker

IPC分类号： A01H5/02

CPC分类号： A01H5/02 ,  A61K36/537

摘要： ‘JEREMY’ is a new and distinctive variety of Salvia which is characterized by a broad, spreading growth habit, an obovate plant form, dark green foliage with greyed-purple venation and petioles, an abundance of pink and white bicolored labiate flowers borne on terminal verticillaster inflorescences, and a floriferous flowering habit. The new variety propagates successfully by stem cuttings and has shown to be uniform and stable in the resulting generations from asexual propagation.

公开(公告)号：US20170296609A1

公开(公告)日：2017-10-19

申请号：US15207307

申请日：2016-07-11

申请人： Fairhaven Health, LLC

发明人： Joanna E. Ellington ,  G. Dennis Clifton

IPC分类号： A61K36/537 ,  A61K47/32 ,  A61K47/26 ,  A61K47/10 ,  A61K47/06 ,  A61K47/02 ,  A61K9/00 ,  A61K47/38

CPC分类号： A61K36/537 ,  A61K8/042 ,  A61K8/60 ,  A61K8/97 ,  A61K9/0014 ,  A61K9/0034 ,  A61K9/06 ,  A61K31/7004 ,  A61K47/02 ,  A61K47/06 ,  A61K47/10 ,  A61K47/12 ,  A61K47/22 ,  A61K47/26 ,  A61K47/32 ,  A61K47/38 ,  A61Q19/10

摘要： The present disclosure provides compositions and methods for making and using topical compositions comprised of an isotonic, biome-friendly solution containing xylose and/or a Salvia extract. The compositions are useful for, for example, maintaining or enhancing female lower reproductive tract (LRT) homeostasis and physiological function. In particular, topical compositions of this disclosure can be formulated for use as a freshening, menopausal, fertility, and/or perineal composition.

公开(公告)号：US09763897B2

公开(公告)日：2017-09-19

申请号：US14658457

申请日：2015-03-16

申请人： U.S. NUTRACEUTICALS, LLC

发明人： John A. Minatelli ,  W. Stephen Hill ,  Rudi E. Moerck

IPC分类号： A61K31/122 ,  A61K31/202 ,  A61K9/48 ,  A61K31/685 ,  A61K31/7028 ,  A61K35/612 ,  A61K36/05 ,  A61K36/535 ,  A61K36/537 ,  A61K36/55 ,  A61K45/06 ,  A61K31/66 ,  A61K35/60 ,  A23P10/30 ,  A23L33/105 ,  A23L33/115

CPC分类号： A61K31/122 ,  A23L33/105 ,  A23L33/115 ,  A23P10/30 ,  A61K9/48 ,  A61K9/4858 ,  A61K31/202 ,  A61K31/66 ,  A61K31/685 ,  A61K31/7028 ,  A61K35/60 ,  A61K35/612 ,  A61K36/05 ,  A61K36/535 ,  A61K36/537 ,  A61K36/55 ,  A61K45/06 ,  A61K2300/00

摘要： A dietary supplement includes comprising a therapeutic amount of astaxanthin derived from a synthetic or natural ester or diol, and at least one of a phospholipid, glycolipid, and sphingolipid, and formulated into an oral dosage form, wherein the astaxanthin is 0.1 to 15 percent by weight of the at least one phospholipid, glycolipid, and sphingolipid. The composition includes 0.5 to 12 mg of astaxanthin and may be used to treat low density lipoprotein (LDL) oxidation in humans and other diseases, disorders and impairments.